Immunoassays News and Research

RSS
Lateral flow assays detect a compound of interest in a compact, paper-based system. Tests such as pregnancy tests are based on lateral flow assays, with many more available for various compounds or even pathogens.
Immunoassay heterogeneity and implications for SARS-CoV-2 serosurveillance

Immunoassay heterogeneity and implications for SARS-CoV-2 serosurveillance

INTEGRA’s electronic pipettes eliminate user fatigue and improve pipetting productivity

INTEGRA’s electronic pipettes eliminate user fatigue and improve pipetting productivity

Salivary IgG to SARS-CoV-2 after mild COVID-19

Salivary IgG to SARS-CoV-2 after mild COVID-19

Antibody and T cell response to SARS-CoV-2 persist up to 8 months: Study of Ski Resort Ischgl

Antibody and T cell response to SARS-CoV-2 persist up to 8 months: Study of Ski Resort Ischgl

Study shows antibody responses persisting 10 months after SARS-CoV-2 infection

Study shows antibody responses persisting 10 months after SARS-CoV-2 infection

Domestic dogs unlikely to transmit SARS-CoV-2, say researchers

Domestic dogs unlikely to transmit SARS-CoV-2, say researchers

Novel gel electrophoresis method for MS-based quantification of protein biomarkers

Novel gel electrophoresis method for MS-based quantification of protein biomarkers

Gyros Protein Technologies introduces Gyrolab Bioaffy 4000 CD to extend sensitivity of immunoassay CD range

Gyros Protein Technologies introduces Gyrolab Bioaffy 4000 CD to extend sensitivity of immunoassay CD range

SARS-CoV-2 anti-N rigid monoclonal antibodies provide accurate early diagnosis

SARS-CoV-2 anti-N rigid monoclonal antibodies provide accurate early diagnosis

Reliable Antibodies Testing for SARS-CoV-2

Reliable Antibodies Testing for SARS-CoV-2

SARS-CoV-2 immunity in the U.S. remains low

SARS-CoV-2 immunity in the U.S. remains low

Bioelectronic rapid test for COVID-19

Bioelectronic rapid test for COVID-19

Temporal predictors of SARS-CoV-2 antibodies

Temporal predictors of SARS-CoV-2 antibodies

Production of six monoclonal antibodies against SARS-CoV-2 spike protein

Production of six monoclonal antibodies against SARS-CoV-2 spike protein

AbC-19 blood test detects COVID-19 antibodies 20 weeks after first symptoms/PCR positive result

AbC-19 blood test detects COVID-19 antibodies 20 weeks after first symptoms/PCR positive result

Discovery of high affinity binders for SARS-CoV-2 spike protein

Discovery of high affinity binders for SARS-CoV-2 spike protein

Self-collection of blood for COVID-19 antibody testing may be a reliable and easy alternative

Self-collection of blood for COVID-19 antibody testing may be a reliable and easy alternative

Complex SARS-CoV-2 serology means universal immunological assay is not feasible

Complex SARS-CoV-2 serology means universal immunological assay is not feasible

Siemens’ SARS-CoV-2 antibody immunoassays meet regulatory targets

Siemens’ SARS-CoV-2 antibody immunoassays meet regulatory targets

New Gyrolab AAVX Titer Kit launched to support the development cell and gene therapies

New Gyrolab AAVX Titer Kit launched to support the development cell and gene therapies